Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 21.15
0.00 (0.00%)
May 16, 2025, 10:07 AM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 630.97 million as of May 16, 2025. Its market cap has decreased by -21.01% in one year.
Market Cap
630.97M
Enterprise Value
538.54M
Revenue
201.71M
Ranking
n/a
PE Ratio
629.71
Stock Price
21.15
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 630.97M, a decrease of -67.49%. That is a compound annual growth rate of -20.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 630.97M | -0.70% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | 826.00M | -57.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 167.85B |
| Caliway Biopharmaceuticals | 121.06B |
| Bora Pharmaceuticals Co., LTD. | 73.80B |
| Lotus Pharmaceutical | 58.85B |
| Polaris Group | 33.54B |
| Oneness Biotech | 29.70B |
| Pegavision | 27.42B |
| Center Laboratories | 26.98B |